Navigation Links
DATATRAK International Reports Fourth Quarter and Full Year Results for 2007
Date:2/26/2008

nternational, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(Unaudited)

For the Twelve Months

Ended December 31,

2007 2006

Revenue $10,561,868 $17,690,336

Direct costs 4,582,829 5,221,665

Gross profit 5,979,039 12,468,671

Selling, general and administrative expenses 13,096,953 13,266,618

Severance expense 915,117 294,974

Depreciation and amortization 2,721,966 2,306,382

Impairment loss 213,209 ---

Loss from operations (10,968,206) (3,399,303)

Interest income 440,158 237,763

Interest expense (369,755) (352,870)

Other expense (1,700) ---

Loss before income taxes (10,899,503) (3,514,410)

Income tax expense (benefit) (46,000) 976,000

Net loss $(10,853,503) $(4,490,410)

Net loss per share:

Basic:

Net loss per share $(0.82) $(0.40)

Weighted average shares outstanding 13,197,706 11,273,382

Diluted:

Net loss per share $(0.82) $(0.40)

Weighted average shares outstanding 13,197,706 11,273,382


'/>"/>
SOURCE DATATRAK International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. DATATRAK International Management to Host Conference Call on February 26, 2008 to Discuss Fourth Quarter and Full Year Operating Results for 2007
2. DATATRAK Closes Second Multi-Year Enterprise Agreement with European Clinical Trial Sponsor
3. DATATRAK to Present at the Roth Capital Partners 20th Annual Orange County Stock Conference
4. DATATRAK International Launches Innovative, Interactive Educational Webcast Series
5. DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results
6. DATATRAK International Management To Host Conference Call on November 8, 2007 To Discuss Third Quarter and Nine Month Operating Results for 2007
7. PRA International to Open Expanded Clinical Pharmacology Center
8. International Federation of Sports Medicine Selects Celadrin(R) Topical Cream as its First and Only Official Joint and Muscle Topical Cream
9. 2008 International Stroke Conference Highlights Impact of Merci Retrieval System
10. Pezcoller Foundation-AACR International Award for Cancer Research recognizes Axel Ullrich
11. Logistical information for the 2008 International Stroke Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- Losing has never felt so good for "The ... new lifestyle means continuing to make smart choices everyday ... is one healthy choice that is an important part ... can take. Every glass of milk has nine essential ... maintain normal blood pressure, and calcium and vitamin D ...
(Date:12/16/2009)... LAUREL, Md., Dec. 16 For ... Army Medical Center in Washington, D.C., the holidays can ... aren,t able to travel home rely more than ever ... friends. This week, calling home just got easier ... in free calling cards, which will provide hundreds of ...
(Date:12/16/2009)... As a result of C3: Colorectal Cancer Coalition,s advocacy ... research program is included in the final Fiscal Year ... research program will research cancers, like colorectal cancer, that ... ovarian cancer research programs run by the U.S. Army ... $15 million in funding for this new cancer research ...
(Date:12/16/2009)... attack is long-term goal, researchers say , , WEDNESDAY, ... tool to predict whether a patient will suffer a ... , "This is an important new tool because studies ... soon after a first stroke are more likely to ... Massachusetts General Hospital and Harvard Medical School, said in ...
(Date:12/16/2009)... reducing inflammation in the lungs , , WEDNESDAY, Dec. 16 ... role in inflammation seems to protect the lungs of ... , Researchers also found that adult smokers with this ... of developing chronic obstructive pulmonary disease (COPD), a progressive ... seems to be protective of the lungs in both ...
Breaking Medicine News(10 mins):Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2Health News:House Creates New Cancer Research Program 2Health News:House Creates New Cancer Research Program 3Health News:New Stroke Tool May Predict Early Recurrence 2Health News:Gene Variant Seems to Guard Against Asthma, COPD 2Health News:Gene Variant Seems to Guard Against Asthma, COPD 3
... forced displacement, forced labor, attacks by soldiers on civilians, ... supplies, have been widespread in eastern Burma (also known ... areas reporting incidents in the 12 months prior to ... the Johns Hopkins Bloomberg School of Public Health, Back ...
... CHICAGO, Oct. 5 Should companies provide fitness,centers for ... worth,it? Does it make a difference? These and ... Corporate,Fitness Show, to be held in conjunction with Club ... Featuring panelists from a broad spectrum of the industry, ...
... Oct. 5 Caraco Pharmaceutical,Laboratories, Ltd., (Amex: ... and Drug,Administration (FDA) has granted tentative approval for ... Hydrochloride,Chewable Tablets, 5 mg and 10 mg (Cetirizine ... anticipated subsequent to the expiry of patent,protection on ...
... to Fly; Case Could Set Precedent for Airline Travel Rights of Persons ... ... A 26-year-old disabled man,who was denied access to a U.S. Airways ... is affected by dystonia, an obscure neuromuscular movement,disorder that causes muscles to ...
... MaxLife Fund Corp.,(OTC:MXFD), announced today that they have retained ... the company options to be listed on the NASDAQ,Capital ... NASDAQ Capital Market will,provide greater visibility for our operations, ... shareholders and potential investors. MaxLife Fund Corp. is ...
... ARBOR, Mich., Oct. 5 NanoBio(R) Corporation, a,biopharmaceutical ... and treatment of infectious diseases, has been honored ... The annual business awards honor Michigan companies ... from their,peers. The awards are bestowed by Michigan ...
Other Medicine News:Health News:Human rights violations widespread in eastern Burma 2Health News:Human rights violations widespread in eastern Burma 3Health News:Corporate Fitness Show to Debut in Chicago October 10-13 2Health News:Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R) 2Health News:Major US Airline Discriminates Against Disabled Passenger, Lawsuit Charges 2Health News:NanoBio Wins 2007 Michigan Innovation Award 2
(Date:12/16/2009)... Inc.,today announced that it was awarded the 2009 ... New England Venture Summit, held on December 8th,at ... private companies,driving the future of innovation, was granted ... held companies that play a leading role in ... , "We are honored ...
(Date:12/16/2009)... AMSTERDAM, December 16 Today, Avantium ... Executive Officer of its pharmaceutical,business. Gunnar Staaf ... and Eli Lilly & Company, in a ... is an important step in Avantium,s plan ... to create a,stand-alone pharmaceutical company based on ...
(Date:12/16/2009)... and ANN ARBOR, Mich., Dec. 16 ... and NanoBio Corporation today announced an exclusive licensing ... the over-the-counter (OTC) use of NB-001, a novel, ... treatment of cold sores. Developed by NanoBio, NB-001 ... causes cold sores, herpes labialis . ...
Breaking Medicine Technology:Biovista Inc. Named Top Innovator in Life Sciences 2Avantium Appoints Gunnar Staaf as CEO Pharma 2GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment 2Free Pills from Government Boost Potassium Iodide Sales 59040 1Free Pills from Government Boost Potassium Iodide Sales 59040 2The Worlds Only Online Marketplace Dedicated to Buying and Selling Gently Used and New Special Needs Equipment 3A DifferentNeedz com 5284 1The Worlds Only Online Marketplace Dedicated to Buying and Selling Gently Used and New Special Needs Equipment 3A DifferentNeedz com 5284 2Marc J Fagel of the U S Securities and Exchange Commission to Discuss SEC Enforcement at CBIs Biotech Pharma Finance and Accounting Forum in San Fra 5282 1Marc J Fagel of the U S Securities and Exchange Commission to Discuss SEC Enforcement at CBIs Biotech Pharma Finance and Accounting Forum in San Fra 5282 2
... Evaluate Safety of CCL2-LPM for Inflammatory Kidney DiseaseSAN ... announced today that patient dosing has commenced in ... lead compound, CCL2-LPM, for the treatment of IgA ... U.S.A. is developing novel chemokine-enzyme fusion protein therapeutics, ...
... Dendreon Corporation (Nasdaq: DNDN ) will host ... 9:00 AM ET (6:00 AM PT) to review the ... for Prostate AdenoCarcinoma Treatment, also known as D9902B) clinical ... immunotherapy for the treatment of advanced prostate cancer. ...
Other Medicine Technology:Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy 2Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy 3Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial 2
... technologies and designs, the Digital ClearMag ... of the posterior pole. Using this ... previously unattainable with the binocular indirect ... and comprehensive views, helping to reduce ...
... Our ELISA products for autoimmune testing ... ELISAs, as well as specific reflex tests ... Sm, Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 ... family includes a full line of products ...
... testing feature single-well ANA screen and ENA ... tests including dsDNA, and 6 individual ENA ... Scl-70 and Jo-1. In addition, our autoimmune ... products for Cardiolipins (IgA, IgG, IgM), Thyroglobulin, ...
... specific second-generation peptide-based test, DIASTAT Anti-CCP* is ... autoantibodies against the cyclic citrullinated peptide (CCP) ... or plasma. Enabling early and accurate diagnosis ... additional tool in the diagnosis and management ...
Medicine Products: